文献速递皮肤肿瘤

Bowen病患者治疗偏好的离散选择实验

Patient preferences for the treatment of Bowen disease.
PubMed 文献 · Br J Dermatol · 2025-01-01

本研究在随机对照非劣效试验中嵌套离散选择实验,评估215例Bowen病患者对手术切除、MAL-PDT和5-FU霜的偏好。混合logit模型显示患者明显偏好手术切除,非侵入性治疗中5-FU霜优于MAL-PDT,且疗效、美容效果和副作用影响选择。

要点

  • 患者对手术切除有明确偏好,非侵入性治疗标签效应为负。
  • 非侵入性治疗中,5-FU霜比MAL-PDT更受偏好。
  • 疗效、美容效果和副作用是影响治疗选择的重要属性。

核心结论

  • 患者对Bowen病手术切除有明确偏好,非侵入性治疗中5-FU霜优于MAL-PDT。

研究设计与样本

  • 离散选择实验嵌套于比较手术切除、MAL-PDT和5-FU霜的随机对照非劣效试验,共215例患者完成。

主要发现

  • 患者对手术切除有明确偏好,非侵入性治疗标签效应大且为负。
  • 中等和良好至优秀美容效果均被接受并优于差美容效果。
  • 无或轻至中度副作用被认为可接受并优于严重副作用。

临床怎么用

  • 共享决策时应讨论患者重视的治疗属性以确保知情选择。
  • 未来研究可探索提高非侵入性治疗吸引力的方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Discrete choice experiments (DCEs) are increasingly used to understand and quantify patient preferences for a variety of treatments, services or screening in order to analyse the choices patients make when faced with different alternatives. OBJECTIVES: The aim of this DCE was to examine patient preferences for the treatment of Bowen disease. METHODS: A DCE was conducted alongside a randomized controlled noninferiority trial comparing the effectiveness of surgical excision, methyl aminolaevulinate photodynamic therapy (MAL-PDT) and 5-fluorouracil (5-FU) cream as treatments for Bowen disease. Preferences were elicited by presenting patients with choice tasks between surgical excision, MAL-PDT and 5-FU cream with the following attributes: effectiveness, cosmetic outcome, side-effects, treatment duration and process. A mixed logit model was used to account for the panel nature of the data (repeated choices for each respondent) and heterogeneity in preference. RESULTS: A total of 215 patients completed the DCE. Patients have a clear preference for excision and noninvasive therapies were less valued, as indicated by the large and negative label effect. Both moderate and good-to-excellent cosmetic outcomes were accepted and preferred to poor cosmetic outcomes for all treatments. In addition, none or mild-to-moderate side-effects were considered acceptable and preferred to severe side-effects. CONCLUSIONS: Patients show a clear preference for surgical excision, and of the two noninvasive treatments, 5-FU cream is preferred to MAL-PDT. Treatment choice is also determined by attributes such as effectiveness, cosmetic outcome and side-effects. In the context of shared decision making for Bowen disease, it is important to discuss the elements of treatment that patients value to ensure that an informed decision is made. Bowen disease is an early form of skin cancer that appears as red, scaly patches on the skin. It is often found in sun-exposed areas such as the face, arms and legs. It can develop into more serious skin cancer if left untreated. It is more common in older adults in populations with high levels of sun exposure and in people with fair skin. The aim of this trial study was to find out which treatments people with Bowen disease prefer and why. We compared three treatments: surgery to cut out the affected skin, a special cream used with light therapy (MAL-PDT) and a cream that kills cancer cells (5-FU). We asked 215 patients in the Netherlands to choose between these treatments based on several factors. These were effectiveness, appearance of the skin after treatment, side-effects and duration of treatment. Most patients preferred surgical removal. Of the non-surgical options, patients preferred 5-FU cream to MAL-PDT. Patients preferred treatments that were effective, had good cosmetic results and had fewer or milder side-effects. These results suggest that clinicians should discuss these factors with patients when choosing the treatment for Bowen disease. This would help patients to make an informed choice based on their preferences. Future research could explore ways to improve the attractiveness of non-invasive treatments.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Ahmady S, Mosterd K, Jansen MHE, et al. Patient preferences for the treatment of Bowen disease. Br J Dermatol. 2025. PMID: 39657744. doi:10.1093/bjd/ljae477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。